Proceedings of a consensus conference: the screening of blood donors for variant CJD1 1This Consensus Conference took place at the Ritz Carlton Hotel in Montreal, Quebec, on March 26–28, 2003, and was chaired by Dr. Gilles Delage of Héma Québec.
Authors:
- Morris A. BlajchmanMBMorris A. Blajchman
- Mindy GoldmanMGMindy Goldman
- Kathryn E. WebertKWKathryn E. Webert
- Eleftherios C. VamvakasEleftherios C. Vamvakas
- Judith HannonJHJudith Hannon
- Gilles DelageGDGilles Delage
- 1 April 2004
- journal article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 18 (2) , 73-92
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Accumulation of prion protein in tonsil and appendix: review of tissue samplesBMJ, 2002
- Estimating the human health risk from possible BSE infection of the British sheep flockNature, 2002
- Predictability of the UK Variant Creutzfeldt-Jakob Disease EpidemicScience, 2001
- Estimation of Epidemic Size and Incubation Time Based on Age Characteristics of vCJD in the United KingdomScience, 2001
- Geographical distribution of variant Creutzfeldt-Jakob disease in Great Britain, 1994–2000The Lancet, 2001
- Iatrogenic Creutzfeldt–Jakob disease at the millenniumNeurology, 2000
- Predicted vCJD mortality in Great BritainNature, 2000
- Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion proteinProceedings Of The Royal Society B-Biological Sciences, 2000
- Phenotype-genotype studies in kuru: Implications for new variant Creutzfeldt–Jakob diseaseProceedings of the National Academy of Sciences, 1998
- Predicting the CJD epidemic in humansNature, 1997